nodes	percent_of_prediction	percent_of_DWPC	metapath
Dicyclomine—Neurological symptom—Lomustine—brain cancer	0.077	0.0776	CcSEcCtD
Dicyclomine—Thrombosis—Procarbazine—brain cancer	0.0209	0.021	CcSEcCtD
Dicyclomine—Disorientation—Lomustine—brain cancer	0.0189	0.019	CcSEcCtD
Dicyclomine—Lethargy—Lomustine—brain cancer	0.0172	0.0174	CcSEcCtD
Dicyclomine—Thrombosis—Carmustine—brain cancer	0.0131	0.0131	CcSEcCtD
Dicyclomine—Disorientation—Procarbazine—brain cancer	0.012	0.0121	CcSEcCtD
Dicyclomine—Necrosis—Carmustine—brain cancer	0.0118	0.0119	CcSEcCtD
Dicyclomine—Lethargy—Procarbazine—brain cancer	0.0109	0.011	CcSEcCtD
Dicyclomine—Speech disorder—Carmustine—brain cancer	0.0107	0.0108	CcSEcCtD
Dicyclomine—Diplopia—Procarbazine—brain cancer	0.0107	0.0108	CcSEcCtD
Dicyclomine—Speech disorder—Temozolomide—brain cancer	0.0104	0.0105	CcSEcCtD
Dicyclomine—Disorientation—Hydroxyurea—brain cancer	0.00927	0.00934	CcSEcCtD
Dicyclomine—Injection site reaction—Carmustine—brain cancer	0.00918	0.00925	CcSEcCtD
Dicyclomine—Necrosis—Etoposide—brain cancer	0.0091	0.00917	CcSEcCtD
Dicyclomine—Tingling sensation—Etoposide—brain cancer	0.00889	0.00895	CcSEcCtD
Dicyclomine—Numbness—Etoposide—brain cancer	0.00862	0.00868	CcSEcCtD
Dicyclomine—Apnoea—Etoposide—brain cancer	0.00843	0.00849	CcSEcCtD
Dicyclomine—Drowsiness—Procarbazine—brain cancer	0.00826	0.00832	CcSEcCtD
Dicyclomine—Sensory loss—Etoposide—brain cancer	0.00825	0.00831	CcSEcCtD
Dicyclomine—Pain—Carboplatin—brain cancer	0.00811	0.00817	CcSEcCtD
Dicyclomine—Face oedema—Hydroxyurea—brain cancer	0.00801	0.00807	CcSEcCtD
Dicyclomine—Anorexia—Lomustine—brain cancer	0.00791	0.00797	CcSEcCtD
Dicyclomine—Thrombophlebitis—Carmustine—brain cancer	0.00775	0.0078	CcSEcCtD
Dicyclomine—Breast disorder—Hydroxyurea—brain cancer	0.0075	0.00755	CcSEcCtD
Dicyclomine—Thrombophlebitis—Temozolomide—brain cancer	0.00749	0.00754	CcSEcCtD
Dicyclomine—Hallucination—Procarbazine—brain cancer	0.00738	0.00743	CcSEcCtD
Dicyclomine—Decreased appetite—Lomustine—brain cancer	0.00721	0.00727	CcSEcCtD
Dicyclomine—Amnesia—Carmustine—brain cancer	0.00714	0.00719	CcSEcCtD
Dicyclomine—Nasal congestion—Temozolomide—brain cancer	0.00711	0.00717	CcSEcCtD
Dicyclomine—Amnesia—Temozolomide—brain cancer	0.0069	0.00695	CcSEcCtD
Dicyclomine—Diplopia—Carmustine—brain cancer	0.00671	0.00676	CcSEcCtD
Dicyclomine—Diplopia—Temozolomide—brain cancer	0.00648	0.00653	CcSEcCtD
Dicyclomine—Face oedema—Carmustine—brain cancer	0.00647	0.00652	CcSEcCtD
Dicyclomine—Drowsiness—Hydroxyurea—brain cancer	0.00639	0.00644	CcSEcCtD
Dicyclomine—Affect lability—Temozolomide—brain cancer	0.00638	0.00643	CcSEcCtD
Dicyclomine—Tension—Procarbazine—brain cancer	0.00633	0.00638	CcSEcCtD
Dicyclomine—Nervousness—Procarbazine—brain cancer	0.00627	0.00632	CcSEcCtD
Dicyclomine—Face oedema—Temozolomide—brain cancer	0.00626	0.0063	CcSEcCtD
Dicyclomine—Mood swings—Temozolomide—brain cancer	0.00614	0.00618	CcSEcCtD
Dicyclomine—Muscular weakness—Carmustine—brain cancer	0.00591	0.00596	CcSEcCtD
Dicyclomine—Breast disorder—Temozolomide—brain cancer	0.00586	0.0059	CcSEcCtD
Dicyclomine—Syncope—Procarbazine—brain cancer	0.00579	0.00583	CcSEcCtD
Dicyclomine—Muscular weakness—Temozolomide—brain cancer	0.00572	0.00576	CcSEcCtD
Dicyclomine—Hallucination—Hydroxyurea—brain cancer	0.00571	0.00575	CcSEcCtD
Dicyclomine—Loss of consciousness—Procarbazine—brain cancer	0.00567	0.00572	CcSEcCtD
Dicyclomine—Abdominal distension—Temozolomide—brain cancer	0.00564	0.00568	CcSEcCtD
Dicyclomine—Hypertension—Procarbazine—brain cancer	0.00557	0.00561	CcSEcCtD
Dicyclomine—Dry mouth—Procarbazine—brain cancer	0.00537	0.00541	CcSEcCtD
Dicyclomine—Confusional state—Procarbazine—brain cancer	0.00531	0.00535	CcSEcCtD
Dicyclomine—Vomiting—Lomustine—brain cancer	0.00528	0.00531	CcSEcCtD
Dicyclomine—Oedema—Procarbazine—brain cancer	0.00527	0.00531	CcSEcCtD
Dicyclomine—Shock—Procarbazine—brain cancer	0.00518	0.00522	CcSEcCtD
Dicyclomine—Erectile dysfunction—Temozolomide—brain cancer	0.00516	0.0052	CcSEcCtD
Dicyclomine—Tachycardia—Procarbazine—brain cancer	0.00514	0.00518	CcSEcCtD
Dicyclomine—Anorexia—Procarbazine—brain cancer	0.00502	0.00506	CcSEcCtD
Dicyclomine—Erythema—Hydroxyurea—brain cancer	0.005	0.00503	CcSEcCtD
Dicyclomine—Nausea—Lomustine—brain cancer	0.00493	0.00496	CcSEcCtD
Dicyclomine—Insomnia—Procarbazine—brain cancer	0.00476	0.0048	CcSEcCtD
Dicyclomine—Paraesthesia—Procarbazine—brain cancer	0.00473	0.00477	CcSEcCtD
Dicyclomine—Somnolence—Procarbazine—brain cancer	0.00468	0.00472	CcSEcCtD
Dicyclomine—Ill-defined disorder—Hydroxyurea—brain cancer	0.00463	0.00467	CcSEcCtD
Dicyclomine—Hallucination—Carmustine—brain cancer	0.00462	0.00465	CcSEcCtD
Dicyclomine—Hypoaesthesia—Carmustine—brain cancer	0.00462	0.00465	CcSEcCtD
Dicyclomine—Decreased appetite—Procarbazine—brain cancer	0.00458	0.00461	CcSEcCtD
Dicyclomine—Fatigue—Procarbazine—brain cancer	0.00454	0.00458	CcSEcCtD
Dicyclomine—Malaise—Hydroxyurea—brain cancer	0.0045	0.00454	CcSEcCtD
Dicyclomine—Constipation—Procarbazine—brain cancer	0.0045	0.00454	CcSEcCtD
Dicyclomine—Pain—Procarbazine—brain cancer	0.0045	0.00454	CcSEcCtD
Dicyclomine—Hypoaesthesia—Temozolomide—brain cancer	0.00446	0.00449	CcSEcCtD
Dicyclomine—Hallucination—Temozolomide—brain cancer	0.00446	0.00449	CcSEcCtD
Dicyclomine—Feeling abnormal—Procarbazine—brain cancer	0.00434	0.00437	CcSEcCtD
Dicyclomine—Eye disorder—Carmustine—brain cancer	0.00434	0.00437	CcSEcCtD
Dicyclomine—Gastrointestinal pain—Procarbazine—brain cancer	0.00431	0.00434	CcSEcCtD
Dicyclomine—Discomfort—Hydroxyurea—brain cancer	0.0042	0.00423	CcSEcCtD
Dicyclomine—Eye disorder—Temozolomide—brain cancer	0.00419	0.00422	CcSEcCtD
Dicyclomine—Urticaria—Procarbazine—brain cancer	0.00418	0.00422	CcSEcCtD
Dicyclomine—Abdominal pain—Procarbazine—brain cancer	0.00416	0.0042	CcSEcCtD
Dicyclomine—Cardiac disorder—Temozolomide—brain cancer	0.00416	0.00419	CcSEcCtD
Dicyclomine—Oedema—Hydroxyurea—brain cancer	0.00408	0.00411	CcSEcCtD
Dicyclomine—Mental disorder—Carmustine—brain cancer	0.00406	0.00409	CcSEcCtD
Dicyclomine—Immune system disorder—Temozolomide—brain cancer	0.00405	0.00408	CcSEcCtD
Dicyclomine—Mediastinal disorder—Temozolomide—brain cancer	0.00404	0.00407	CcSEcCtD
Dicyclomine—Erythema—Carmustine—brain cancer	0.00404	0.00407	CcSEcCtD
Dicyclomine—Nervous system disorder—Hydroxyurea—brain cancer	0.004	0.00403	CcSEcCtD
Dicyclomine—Mental disorder—Temozolomide—brain cancer	0.00393	0.00396	CcSEcCtD
Dicyclomine—Erythema—Temozolomide—brain cancer	0.0039	0.00393	CcSEcCtD
Dicyclomine—Anorexia—Hydroxyurea—brain cancer	0.00389	0.00391	CcSEcCtD
Dicyclomine—Hypersensitivity—Procarbazine—brain cancer	0.00388	0.00391	CcSEcCtD
Dicyclomine—Vision blurred—Carmustine—brain cancer	0.00381	0.00383	CcSEcCtD
Dicyclomine—Asthenia—Procarbazine—brain cancer	0.00378	0.00381	CcSEcCtD
Dicyclomine—Pruritus—Procarbazine—brain cancer	0.00373	0.00375	CcSEcCtD
Dicyclomine—Agitation—Carmustine—brain cancer	0.00371	0.00374	CcSEcCtD
Dicyclomine—Vision blurred—Temozolomide—brain cancer	0.00368	0.00371	CcSEcCtD
Dicyclomine—Dyspnoea—Hydroxyurea—brain cancer	0.00363	0.00366	CcSEcCtD
Dicyclomine—Somnolence—Hydroxyurea—brain cancer	0.00362	0.00365	CcSEcCtD
Dicyclomine—Ill-defined disorder—Temozolomide—brain cancer	0.00362	0.00365	CcSEcCtD
Dicyclomine—Dyspepsia—Hydroxyurea—brain cancer	0.00359	0.00362	CcSEcCtD
Dicyclomine—Agitation—Temozolomide—brain cancer	0.00359	0.00361	CcSEcCtD
Dicyclomine—Hypoaesthesia—Etoposide—brain cancer	0.00357	0.0036	CcSEcCtD
Dicyclomine—Angioedema—Temozolomide—brain cancer	0.00357	0.00359	CcSEcCtD
Dicyclomine—Decreased appetite—Hydroxyurea—brain cancer	0.00354	0.00357	CcSEcCtD
Dicyclomine—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.00352	0.00355	CcSEcCtD
Dicyclomine—Malaise—Temozolomide—brain cancer	0.00352	0.00355	CcSEcCtD
Dicyclomine—Fatigue—Hydroxyurea—brain cancer	0.00351	0.00354	CcSEcCtD
Dicyclomine—Hypertension—Carmustine—brain cancer	0.00349	0.00351	CcSEcCtD
Dicyclomine—Constipation—Hydroxyurea—brain cancer	0.00349	0.00351	CcSEcCtD
Dicyclomine—Pain—Hydroxyurea—brain cancer	0.00349	0.00351	CcSEcCtD
Dicyclomine—Dizziness—Procarbazine—brain cancer	0.00348	0.00351	CcSEcCtD
Dicyclomine—Palpitations—Temozolomide—brain cancer	0.00345	0.00347	CcSEcCtD
Dicyclomine—Hypertension—Temozolomide—brain cancer	0.00337	0.00339	CcSEcCtD
Dicyclomine—Feeling abnormal—Hydroxyurea—brain cancer	0.00336	0.00338	CcSEcCtD
Dicyclomine—Eye disorder—Etoposide—brain cancer	0.00335	0.00338	CcSEcCtD
Dicyclomine—Vomiting—Procarbazine—brain cancer	0.00335	0.00337	CcSEcCtD
Dicyclomine—Cardiac disorder—Etoposide—brain cancer	0.00333	0.00335	CcSEcCtD
Dicyclomine—Confusional state—Carmustine—brain cancer	0.00332	0.00335	CcSEcCtD
Dicyclomine—Rash—Procarbazine—brain cancer	0.00332	0.00335	CcSEcCtD
Dicyclomine—Dermatitis—Procarbazine—brain cancer	0.00332	0.00334	CcSEcCtD
Dicyclomine—Headache—Procarbazine—brain cancer	0.0033	0.00332	CcSEcCtD
Dicyclomine—Oedema—Carmustine—brain cancer	0.0033	0.00332	CcSEcCtD
Dicyclomine—Discomfort—Temozolomide—brain cancer	0.00328	0.00331	CcSEcCtD
Dicyclomine—Dry mouth—Temozolomide—brain cancer	0.00325	0.00327	CcSEcCtD
Dicyclomine—Immune system disorder—Etoposide—brain cancer	0.00324	0.00326	CcSEcCtD
Dicyclomine—Mediastinal disorder—Etoposide—brain cancer	0.00323	0.00326	CcSEcCtD
Dicyclomine—Tachycardia—Carmustine—brain cancer	0.00322	0.00324	CcSEcCtD
Dicyclomine—Confusional state—Temozolomide—brain cancer	0.00321	0.00324	CcSEcCtD
Dicyclomine—Oedema—Temozolomide—brain cancer	0.00318	0.00321	CcSEcCtD
Dicyclomine—Anaphylactic shock—Temozolomide—brain cancer	0.00318	0.00321	CcSEcCtD
Dicyclomine—Anorexia—Carmustine—brain cancer	0.00314	0.00316	CcSEcCtD
Dicyclomine—Nausea—Procarbazine—brain cancer	0.00313	0.00315	CcSEcCtD
Dicyclomine—Nervous system disorder—Temozolomide—brain cancer	0.00312	0.00315	CcSEcCtD
Dicyclomine—Anorexia—Temozolomide—brain cancer	0.00304	0.00306	CcSEcCtD
Dicyclomine—Hypersensitivity—Hydroxyurea—brain cancer	0.003	0.00303	CcSEcCtD
Dicyclomine—Insomnia—Carmustine—brain cancer	0.00298	0.003	CcSEcCtD
Dicyclomine—Paraesthesia—Carmustine—brain cancer	0.00296	0.00298	CcSEcCtD
Dicyclomine—Dyspnoea—Carmustine—brain cancer	0.00294	0.00296	CcSEcCtD
Dicyclomine—Somnolence—Carmustine—brain cancer	0.00293	0.00295	CcSEcCtD
Dicyclomine—Asthenia—Hydroxyurea—brain cancer	0.00292	0.00295	CcSEcCtD
Dicyclomine—Ill-defined disorder—Etoposide—brain cancer	0.0029	0.00292	CcSEcCtD
Dicyclomine—Insomnia—Temozolomide—brain cancer	0.00288	0.0029	CcSEcCtD
Dicyclomine—Decreased appetite—Carmustine—brain cancer	0.00286	0.00289	CcSEcCtD
Dicyclomine—Paraesthesia—Temozolomide—brain cancer	0.00286	0.00288	CcSEcCtD
Dicyclomine—Gastrointestinal disorder—Carmustine—brain cancer	0.00285	0.00287	CcSEcCtD
Dicyclomine—Dyspnoea—Temozolomide—brain cancer	0.00284	0.00286	CcSEcCtD
Dicyclomine—Somnolence—Temozolomide—brain cancer	0.00283	0.00285	CcSEcCtD
Dicyclomine—Pain—Carmustine—brain cancer	0.00282	0.00284	CcSEcCtD
Dicyclomine—Constipation—Carmustine—brain cancer	0.00282	0.00284	CcSEcCtD
Dicyclomine—Malaise—Etoposide—brain cancer	0.00282	0.00284	CcSEcCtD
Dicyclomine—Dyspepsia—Temozolomide—brain cancer	0.0028	0.00282	CcSEcCtD
Dicyclomine—Decreased appetite—Temozolomide—brain cancer	0.00277	0.00279	CcSEcCtD
Dicyclomine—Gastrointestinal disorder—Temozolomide—brain cancer	0.00275	0.00277	CcSEcCtD
Dicyclomine—Fatigue—Temozolomide—brain cancer	0.00275	0.00277	CcSEcCtD
Dicyclomine—Loss of consciousness—Etoposide—brain cancer	0.00274	0.00276	CcSEcCtD
Dicyclomine—Constipation—Temozolomide—brain cancer	0.00272	0.00274	CcSEcCtD
Dicyclomine—Pain—Temozolomide—brain cancer	0.00272	0.00274	CcSEcCtD
Dicyclomine—Feeling abnormal—Carmustine—brain cancer	0.00272	0.00274	CcSEcCtD
Dicyclomine—Hypertension—Etoposide—brain cancer	0.0027	0.00272	CcSEcCtD
Dicyclomine—Dizziness—Hydroxyurea—brain cancer	0.0027	0.00272	CcSEcCtD
Dicyclomine—Gastrointestinal pain—Carmustine—brain cancer	0.00269	0.00271	CcSEcCtD
Dicyclomine—Discomfort—Etoposide—brain cancer	0.00263	0.00265	CcSEcCtD
Dicyclomine—Feeling abnormal—Temozolomide—brain cancer	0.00262	0.00264	CcSEcCtD
Dicyclomine—Abdominal pain—Carmustine—brain cancer	0.00261	0.00262	CcSEcCtD
Dicyclomine—Gastrointestinal pain—Temozolomide—brain cancer	0.0026	0.00262	CcSEcCtD
Dicyclomine—Vomiting—Hydroxyurea—brain cancer	0.00259	0.00261	CcSEcCtD
Dicyclomine—Rash—Hydroxyurea—brain cancer	0.00257	0.00259	CcSEcCtD
Dicyclomine—Confusional state—Etoposide—brain cancer	0.00257	0.00259	CcSEcCtD
Dicyclomine—Dermatitis—Hydroxyurea—brain cancer	0.00257	0.00259	CcSEcCtD
Dicyclomine—Headache—Hydroxyurea—brain cancer	0.00255	0.00257	CcSEcCtD
Dicyclomine—Anaphylactic shock—Etoposide—brain cancer	0.00255	0.00257	CcSEcCtD
Dicyclomine—Urticaria—Temozolomide—brain cancer	0.00253	0.00255	CcSEcCtD
Dicyclomine—Abdominal pain—Temozolomide—brain cancer	0.00252	0.00254	CcSEcCtD
Dicyclomine—Tachycardia—Etoposide—brain cancer	0.00249	0.00251	CcSEcCtD
Dicyclomine—Anorexia—Etoposide—brain cancer	0.00243	0.00245	CcSEcCtD
Dicyclomine—Hypersensitivity—Carmustine—brain cancer	0.00243	0.00245	CcSEcCtD
Dicyclomine—Nausea—Hydroxyurea—brain cancer	0.00242	0.00244	CcSEcCtD
Dicyclomine—Asthenia—Carmustine—brain cancer	0.00236	0.00238	CcSEcCtD
Dicyclomine—Hypersensitivity—Temozolomide—brain cancer	0.00235	0.00236	CcSEcCtD
Dicyclomine—Paraesthesia—Etoposide—brain cancer	0.00229	0.00231	CcSEcCtD
Dicyclomine—Asthenia—Temozolomide—brain cancer	0.00229	0.0023	CcSEcCtD
Dicyclomine—Dyspnoea—Etoposide—brain cancer	0.00227	0.00229	CcSEcCtD
Dicyclomine—Somnolence—Etoposide—brain cancer	0.00227	0.00228	CcSEcCtD
Dicyclomine—Pruritus—Temozolomide—brain cancer	0.00225	0.00227	CcSEcCtD
Dicyclomine—Decreased appetite—Etoposide—brain cancer	0.00222	0.00223	CcSEcCtD
Dicyclomine—Gastrointestinal disorder—Etoposide—brain cancer	0.0022	0.00222	CcSEcCtD
Dicyclomine—Fatigue—Etoposide—brain cancer	0.0022	0.00221	CcSEcCtD
Dicyclomine—Dizziness—Carmustine—brain cancer	0.00218	0.0022	CcSEcCtD
Dicyclomine—Pain—Etoposide—brain cancer	0.00218	0.0022	CcSEcCtD
Dicyclomine—Constipation—Etoposide—brain cancer	0.00218	0.0022	CcSEcCtD
Dicyclomine—Dizziness—Temozolomide—brain cancer	0.00211	0.00212	CcSEcCtD
Dicyclomine—Feeling abnormal—Etoposide—brain cancer	0.0021	0.00212	CcSEcCtD
Dicyclomine—Vomiting—Carmustine—brain cancer	0.0021	0.00211	CcSEcCtD
Dicyclomine—Gastrointestinal pain—Etoposide—brain cancer	0.00208	0.0021	CcSEcCtD
Dicyclomine—Rash—Carmustine—brain cancer	0.00208	0.00209	CcSEcCtD
Dicyclomine—Dermatitis—Carmustine—brain cancer	0.00208	0.00209	CcSEcCtD
Dicyclomine—Headache—Carmustine—brain cancer	0.00206	0.00208	CcSEcCtD
Dicyclomine—Vomiting—Temozolomide—brain cancer	0.00202	0.00204	CcSEcCtD
Dicyclomine—Urticaria—Etoposide—brain cancer	0.00202	0.00204	CcSEcCtD
Dicyclomine—Abdominal pain—Etoposide—brain cancer	0.00201	0.00203	CcSEcCtD
Dicyclomine—Rash—Temozolomide—brain cancer	0.00201	0.00202	CcSEcCtD
Dicyclomine—Dermatitis—Temozolomide—brain cancer	0.00201	0.00202	CcSEcCtD
Dicyclomine—Headache—Temozolomide—brain cancer	0.002	0.00201	CcSEcCtD
Dicyclomine—Nausea—Carmustine—brain cancer	0.00196	0.00197	CcSEcCtD
Dicyclomine—Nausea—Temozolomide—brain cancer	0.00189	0.00191	CcSEcCtD
Dicyclomine—Hypersensitivity—Etoposide—brain cancer	0.00188	0.00189	CcSEcCtD
Dicyclomine—Asthenia—Etoposide—brain cancer	0.00183	0.00184	CcSEcCtD
Dicyclomine—Pruritus—Etoposide—brain cancer	0.0018	0.00182	CcSEcCtD
Dicyclomine—Dizziness—Etoposide—brain cancer	0.00169	0.0017	CcSEcCtD
Dicyclomine—Vomiting—Etoposide—brain cancer	0.00162	0.00163	CcSEcCtD
Dicyclomine—Rash—Etoposide—brain cancer	0.00161	0.00162	CcSEcCtD
Dicyclomine—Dermatitis—Etoposide—brain cancer	0.00161	0.00162	CcSEcCtD
Dicyclomine—Headache—Etoposide—brain cancer	0.0016	0.00161	CcSEcCtD
Dicyclomine—Nausea—Etoposide—brain cancer	0.00151	0.00153	CcSEcCtD
Dicyclomine—CYP1A1—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP2C9—brain cancer	0.000824	0.112	CbGpPWpGaD
Dicyclomine—CYP1A1—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP2C9—brain cancer	0.00075	0.102	CbGpPWpGaD
Dicyclomine—CYP1A1—Xenobiotics—CYP2C9—brain cancer	0.000396	0.0537	CbGpPWpGaD
Dicyclomine—CYP1A1—Tamoxifen metabolism—CYP2C9—brain cancer	0.000381	0.0517	CbGpPWpGaD
Dicyclomine—CYP1A1—Arachidonic acid metabolism—CYP2C9—brain cancer	0.00019	0.0258	CbGpPWpGaD
Dicyclomine—CYP1A1—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000164	0.0223	CbGpPWpGaD
Dicyclomine—CYP1A1—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000162	0.022	CbGpPWpGaD
Dicyclomine—CYP1A1—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000133	0.0181	CbGpPWpGaD
Dicyclomine—CHRM1—Regulation of Actin Cytoskeleton—PPP1R12A—brain cancer	0.000121	0.0164	CbGpPWpGaD
Dicyclomine—CHRM3—Regulation of Actin Cytoskeleton—PPP1R12A—brain cancer	0.000121	0.0164	CbGpPWpGaD
Dicyclomine—CHRM2—Regulation of Actin Cytoskeleton—PPP1R12A—brain cancer	0.00012	0.0162	CbGpPWpGaD
Dicyclomine—CHRM2—SIDS Susceptibility Pathways—HES5—brain cancer	0.000104	0.0141	CbGpPWpGaD
Dicyclomine—CYP1A1—Oxidative Stress—SOD2—brain cancer	0.000103	0.0139	CbGpPWpGaD
Dicyclomine—CHRM1—Circadian rythm related genes—NTRK3—brain cancer	8.86e-05	0.012	CbGpPWpGaD
Dicyclomine—CYP1A1—Estrogen Receptor Pathway—STAT3—brain cancer	8.78e-05	0.0119	CbGpPWpGaD
Dicyclomine—CHRM3—GPCRs, Other—SMO—brain cancer	8.13e-05	0.011	CbGpPWpGaD
Dicyclomine—CHRM2—GPCRs, Other—SMO—brain cancer	8.05e-05	0.0109	CbGpPWpGaD
Dicyclomine—CYP1A1—Aryl Hydrocarbon Receptor Pathway—HES1—brain cancer	7.31e-05	0.00991	CbGpPWpGaD
Dicyclomine—CYP1A1—Biological oxidations—CYP2C9—brain cancer	7.08e-05	0.00961	CbGpPWpGaD
Dicyclomine—CYP1A1—Metapathway biotransformation—CYP2C9—brain cancer	6.99e-05	0.00948	CbGpPWpGaD
Dicyclomine—CHRM1—GPCR ligand binding—PTCH2—brain cancer	4.73e-05	0.00642	CbGpPWpGaD
Dicyclomine—CHRM3—GPCR ligand binding—PTCH2—brain cancer	4.72e-05	0.0064	CbGpPWpGaD
Dicyclomine—CHRM2—GPCR ligand binding—PTCH2—brain cancer	4.67e-05	0.00634	CbGpPWpGaD
Dicyclomine—CHRM1—G alpha (q) signalling events—TRPC6—brain cancer	4.66e-05	0.00633	CbGpPWpGaD
Dicyclomine—CHRM3—G alpha (q) signalling events—TRPC6—brain cancer	4.65e-05	0.00631	CbGpPWpGaD
Dicyclomine—CHRM2—SIDS Susceptibility Pathways—ESR2—brain cancer	4.42e-05	0.00599	CbGpPWpGaD
Dicyclomine—CYP1A1—Aryl Hydrocarbon Receptor—RELA—brain cancer	4.21e-05	0.00572	CbGpPWpGaD
Dicyclomine—CHRM1—Regulation of Actin Cytoskeleton—VAV1—brain cancer	4.19e-05	0.00568	CbGpPWpGaD
Dicyclomine—CHRM3—Regulation of Actin Cytoskeleton—VAV1—brain cancer	4.18e-05	0.00567	CbGpPWpGaD
Dicyclomine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—TRPC6—brain cancer	4.17e-05	0.00566	CbGpPWpGaD
Dicyclomine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—TRPC6—brain cancer	4.16e-05	0.00564	CbGpPWpGaD
Dicyclomine—CHRM1—GPCR downstream signaling—OR4C12—brain cancer	4.15e-05	0.00563	CbGpPWpGaD
Dicyclomine—CHRM1—GPCR downstream signaling—OR14C36—brain cancer	4.15e-05	0.00563	CbGpPWpGaD
Dicyclomine—CHRM3—GPCR downstream signaling—OR4C12—brain cancer	4.14e-05	0.00561	CbGpPWpGaD
Dicyclomine—CHRM3—GPCR downstream signaling—OR14C36—brain cancer	4.14e-05	0.00561	CbGpPWpGaD
Dicyclomine—CHRM2—Regulation of Actin Cytoskeleton—VAV1—brain cancer	4.14e-05	0.00561	CbGpPWpGaD
Dicyclomine—CHRM2—GPCR downstream signaling—OR14C36—brain cancer	4.1e-05	0.00556	CbGpPWpGaD
Dicyclomine—CHRM2—GPCR downstream signaling—OR4C12—brain cancer	4.1e-05	0.00556	CbGpPWpGaD
Dicyclomine—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL2—brain cancer	3.8e-05	0.00515	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling by GPCR—OR4C12—brain cancer	3.77e-05	0.00512	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling by GPCR—OR14C36—brain cancer	3.77e-05	0.00512	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling by GPCR—OR14C36—brain cancer	3.76e-05	0.0051	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling by GPCR—OR4C12—brain cancer	3.76e-05	0.0051	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling by GPCR—OR14C36—brain cancer	3.72e-05	0.00505	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling by GPCR—OR4C12—brain cancer	3.72e-05	0.00505	CbGpPWpGaD
Dicyclomine—CHRM1—Regulation of Actin Cytoskeleton—PDGFRA—brain cancer	3.43e-05	0.00466	CbGpPWpGaD
Dicyclomine—CHRM2—SIDS Susceptibility Pathways—HES1—brain cancer	3.43e-05	0.00465	CbGpPWpGaD
Dicyclomine—CHRM3—Regulation of Actin Cytoskeleton—PDGFRA—brain cancer	3.42e-05	0.00464	CbGpPWpGaD
Dicyclomine—CHRM2—Regulation of Actin Cytoskeleton—PDGFRA—brain cancer	3.39e-05	0.0046	CbGpPWpGaD
Dicyclomine—CYP1A1—Aryl Hydrocarbon Receptor—VEGFA—brain cancer	3.23e-05	0.00438	CbGpPWpGaD
Dicyclomine—CYP1A1—Aryl Hydrocarbon Receptor—MYC—brain cancer	2.97e-05	0.00403	CbGpPWpGaD
Dicyclomine—CHRM1—Circadian rythm related genes—SIRT1—brain cancer	2.94e-05	0.00399	CbGpPWpGaD
Dicyclomine—CYP1A1—Aryl Hydrocarbon Receptor—EGFR—brain cancer	2.9e-05	0.00394	CbGpPWpGaD
Dicyclomine—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—brain cancer	2.9e-05	0.00394	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	2.72e-05	0.00369	CbGpPWpGaD
Dicyclomine—CHRM1—Regulation of Actin Cytoskeleton—PIK3CG—brain cancer	2.66e-05	0.00361	CbGpPWpGaD
Dicyclomine—CHRM1—Regulation of Actin Cytoskeleton—APC—brain cancer	2.66e-05	0.00361	CbGpPWpGaD
Dicyclomine—CHRM3—Regulation of Actin Cytoskeleton—PIK3CG—brain cancer	2.65e-05	0.0036	CbGpPWpGaD
Dicyclomine—CHRM3—Regulation of Actin Cytoskeleton—APC—brain cancer	2.65e-05	0.0036	CbGpPWpGaD
Dicyclomine—CHRM2—Regulation of Actin Cytoskeleton—APC—brain cancer	2.63e-05	0.00356	CbGpPWpGaD
Dicyclomine—CHRM2—Regulation of Actin Cytoskeleton—PIK3CG—brain cancer	2.63e-05	0.00356	CbGpPWpGaD
Dicyclomine—CHRM1—GPCR ligand binding—SHH—brain cancer	2.44e-05	0.00331	CbGpPWpGaD
Dicyclomine—CHRM3—GPCR ligand binding—SHH—brain cancer	2.43e-05	0.0033	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling by GPCR—PTCH2—brain cancer	2.43e-05	0.0033	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling by GPCR—PTCH2—brain cancer	2.42e-05	0.00329	CbGpPWpGaD
Dicyclomine—CHRM2—GPCR ligand binding—SHH—brain cancer	2.41e-05	0.00327	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling by GPCR—PTCH2—brain cancer	2.4e-05	0.00325	CbGpPWpGaD
Dicyclomine—CHRM1—GPCR ligand binding—PTCH1—brain cancer	2.31e-05	0.00314	CbGpPWpGaD
Dicyclomine—CHRM1—GPCR ligand binding—SMO—brain cancer	2.31e-05	0.00314	CbGpPWpGaD
Dicyclomine—CHRM3—GPCR ligand binding—SMO—brain cancer	2.3e-05	0.00313	CbGpPWpGaD
Dicyclomine—CHRM3—GPCR ligand binding—PTCH1—brain cancer	2.3e-05	0.00313	CbGpPWpGaD
Dicyclomine—CHRM2—GPCR ligand binding—SMO—brain cancer	2.28e-05	0.0031	CbGpPWpGaD
Dicyclomine—CHRM2—GPCR ligand binding—PTCH1—brain cancer	2.28e-05	0.0031	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—OR14C36—brain cancer	2.23e-05	0.00302	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—OR4C12—brain cancer	2.23e-05	0.00302	CbGpPWpGaD
Dicyclomine—CHRM1—Circadian rythm related genes—CDK4—brain cancer	2.22e-05	0.00302	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—OR4C12—brain cancer	2.22e-05	0.00301	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—OR14C36—brain cancer	2.22e-05	0.00301	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—OR4C12—brain cancer	2.2e-05	0.00298	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—OR14C36—brain cancer	2.2e-05	0.00298	CbGpPWpGaD
Dicyclomine—CHRM1—GPCR downstream signaling—ABR—brain cancer	2.1e-05	0.00285	CbGpPWpGaD
Dicyclomine—CHRM3—GPCR downstream signaling—ABR—brain cancer	2.09e-05	0.00284	CbGpPWpGaD
Dicyclomine—CHRM2—GPCR downstream signaling—ABR—brain cancer	2.07e-05	0.00281	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism of lipids and lipoproteins—IDH1—brain cancer	1.99e-05	0.0027	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling by GPCR—ABR—brain cancer	1.91e-05	0.00259	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling by GPCR—ABR—brain cancer	1.9e-05	0.00258	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—DTX2—brain cancer	1.89e-05	0.00257	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—DTX2—brain cancer	1.89e-05	0.00256	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling by GPCR—ABR—brain cancer	1.88e-05	0.00255	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—DTX2—brain cancer	1.87e-05	0.00254	CbGpPWpGaD
Dicyclomine—CHRM2—SIDS Susceptibility Pathways—CTNNB1—brain cancer	1.72e-05	0.00233	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—CYP2C9—brain cancer	1.52e-05	0.00207	CbGpPWpGaD
Dicyclomine—CHRM2—SIDS Susceptibility Pathways—VEGFA—brain cancer	1.51e-05	0.00205	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—PTCH2—brain cancer	1.44e-05	0.00195	CbGpPWpGaD
Dicyclomine—CHRM1—Regulation of Actin Cytoskeleton—EGFR—brain cancer	1.43e-05	0.00194	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—PTCH2—brain cancer	1.43e-05	0.00194	CbGpPWpGaD
Dicyclomine—CHRM3—Regulation of Actin Cytoskeleton—EGFR—brain cancer	1.43e-05	0.00194	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—PTCH2—brain cancer	1.42e-05	0.00192	CbGpPWpGaD
Dicyclomine—CHRM2—Regulation of Actin Cytoskeleton—EGFR—brain cancer	1.41e-05	0.00192	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—HES5—brain cancer	1.39e-05	0.00189	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—HES5—brain cancer	1.39e-05	0.00188	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—HES5—brain cancer	1.37e-05	0.00186	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—STRADA—brain cancer	1.35e-05	0.00183	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—STRADA—brain cancer	1.34e-05	0.00182	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—STRADA—brain cancer	1.33e-05	0.00181	CbGpPWpGaD
Dicyclomine—CHRM1—GPCR downstream signaling—TRPC6—brain cancer	1.33e-05	0.0018	CbGpPWpGaD
Dicyclomine—CHRM3—GPCR downstream signaling—TRPC6—brain cancer	1.32e-05	0.0018	CbGpPWpGaD
Dicyclomine—CHRM2—GPCR downstream signaling—TRPC6—brain cancer	1.31e-05	0.00178	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—BSG—brain cancer	1.3e-05	0.00176	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling by GPCR—SHH—brain cancer	1.25e-05	0.0017	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling by GPCR—SHH—brain cancer	1.25e-05	0.00169	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling by GPCR—SHH—brain cancer	1.24e-05	0.00168	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—CYP2C9—brain cancer	1.21e-05	0.00164	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling by GPCR—TRPC6—brain cancer	1.21e-05	0.00164	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling by GPCR—TRPC6—brain cancer	1.2e-05	0.00163	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling by GPCR—TRPC6—brain cancer	1.19e-05	0.00162	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling by GPCR—SMO—brain cancer	1.19e-05	0.00161	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling by GPCR—PTCH1—brain cancer	1.19e-05	0.00161	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling by GPCR—SMO—brain cancer	1.18e-05	0.0016	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling by GPCR—PTCH1—brain cancer	1.18e-05	0.0016	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling by GPCR—SMO—brain cancer	1.17e-05	0.00159	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling by GPCR—PTCH1—brain cancer	1.17e-05	0.00159	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—ABR—brain cancer	1.13e-05	0.00153	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—ABR—brain cancer	1.12e-05	0.00152	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—IDH1—brain cancer	1.11e-05	0.00151	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—ABR—brain cancer	1.11e-05	0.00151	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—GLI2—brain cancer	1.09e-05	0.00148	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—GLI2—brain cancer	1.08e-05	0.00147	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—GLI2—brain cancer	1.07e-05	0.00146	CbGpPWpGaD
Dicyclomine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—brain cancer	1.07e-05	0.00145	CbGpPWpGaD
Dicyclomine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—brain cancer	1.06e-05	0.00144	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—BSG—brain cancer	1.03e-05	0.0014	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—GLI1—brain cancer	1.02e-05	0.00139	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—GLI1—brain cancer	1.02e-05	0.00138	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—GLI1—brain cancer	1.01e-05	0.00137	CbGpPWpGaD
Dicyclomine—CHRM1—GPCR downstream signaling—VAV1—brain cancer	9.96e-06	0.00135	CbGpPWpGaD
Dicyclomine—CHRM3—GPCR downstream signaling—VAV1—brain cancer	9.92e-06	0.00135	CbGpPWpGaD
Dicyclomine—CHRM2—GPCR downstream signaling—VAV1—brain cancer	9.83e-06	0.00133	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—SUFU—brain cancer	9.69e-06	0.00132	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—SUFU—brain cancer	9.66e-06	0.00131	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—SUFU—brain cancer	9.57e-06	0.0013	CbGpPWpGaD
Dicyclomine—CHRM1—Circadian rythm related genes—TP53—brain cancer	9.46e-06	0.00128	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—GFAP—brain cancer	9.35e-06	0.00127	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—GFAP—brain cancer	9.32e-06	0.00126	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—GFAP—brain cancer	9.23e-06	0.00125	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling by GPCR—VAV1—brain cancer	9.04e-06	0.00123	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling by GPCR—VAV1—brain cancer	9.01e-06	0.00122	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling by GPCR—VAV1—brain cancer	8.93e-06	0.00121	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—HEY1—brain cancer	8.87e-06	0.0012	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—IDH1—brain cancer	8.86e-06	0.0012	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—HEY1—brain cancer	8.84e-06	0.0012	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—ENO2—brain cancer	8.81e-06	0.0012	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—HEY1—brain cancer	8.75e-06	0.00119	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—DLL1—brain cancer	8.69e-06	0.00118	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—DLL1—brain cancer	8.67e-06	0.00118	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—DLL1—brain cancer	8.58e-06	0.00116	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—SHH—brain cancer	7.39e-06	0.001	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—SHH—brain cancer	7.37e-06	0.001	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—SHH—brain cancer	7.3e-06	0.00099	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	7.21e-06	0.000979	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—TRPC6—brain cancer	7.13e-06	0.000967	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—TRPC6—brain cancer	7.11e-06	0.000964	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—TRPC6—brain cancer	7.04e-06	0.000955	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—PTCH1—brain cancer	7.01e-06	0.000951	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—SMO—brain cancer	7.01e-06	0.000951	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—ENO2—brain cancer	7e-06	0.00095	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—SMO—brain cancer	6.99e-06	0.000948	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—PTCH1—brain cancer	6.99e-06	0.000948	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—PTCH1—brain cancer	6.92e-06	0.000939	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—SMO—brain cancer	6.92e-06	0.000939	CbGpPWpGaD
Dicyclomine—CHRM1—GPCR downstream signaling—PIK3CG—brain cancer	6.32e-06	0.000858	CbGpPWpGaD
Dicyclomine—CHRM3—GPCR downstream signaling—PIK3CG—brain cancer	6.3e-06	0.000855	CbGpPWpGaD
Dicyclomine—CHRM2—GPCR downstream signaling—PIK3CG—brain cancer	6.24e-06	0.000847	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling by GPCR—PIK3CG—brain cancer	5.74e-06	0.000779	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling by GPCR—PIK3CG—brain cancer	5.72e-06	0.000776	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling by GPCR—PIK3CG—brain cancer	5.67e-06	0.000769	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—NOTCH2—brain cancer	5.6e-06	0.00076	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—NOTCH2—brain cancer	5.58e-06	0.000758	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—NOTCH2—brain cancer	5.53e-06	0.00075	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—VAV1—brain cancer	5.34e-06	0.000725	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—VAV1—brain cancer	5.32e-06	0.000722	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—VAV1—brain cancer	5.27e-06	0.000715	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—HES1—brain cancer	4.59e-06	0.000623	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—HES1—brain cancer	4.58e-06	0.000621	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—HES1—brain cancer	4.53e-06	0.000615	CbGpPWpGaD
Dicyclomine—CHRM1—GPCR downstream signaling—IL2—brain cancer	4.45e-06	0.000604	CbGpPWpGaD
Dicyclomine—CHRM3—GPCR downstream signaling—IL2—brain cancer	4.43e-06	0.000602	CbGpPWpGaD
Dicyclomine—CHRM2—GPCR downstream signaling—IL2—brain cancer	4.39e-06	0.000596	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—PDGFRA—brain cancer	4.37e-06	0.000593	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—PDGFRA—brain cancer	4.36e-06	0.000592	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—PDGFRA—brain cancer	4.32e-06	0.000586	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—SPP1—brain cancer	4.25e-06	0.000576	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—SPP1—brain cancer	4.23e-06	0.000574	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—SPP1—brain cancer	4.19e-06	0.000569	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—PIK3CG—brain cancer	4.04e-06	0.000549	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling by GPCR—IL2—brain cancer	4.04e-06	0.000548	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling by GPCR—IL2—brain cancer	4.03e-06	0.000546	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling by GPCR—IL2—brain cancer	3.99e-06	0.000541	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—IRS2—brain cancer	3.84e-06	0.000521	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—IRS2—brain cancer	3.83e-06	0.000519	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—IRS2—brain cancer	3.79e-06	0.000514	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—APC—brain cancer	3.39e-06	0.00046	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—PIK3CG—brain cancer	3.39e-06	0.00046	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—APC—brain cancer	3.38e-06	0.000459	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—PIK3CG—brain cancer	3.38e-06	0.000459	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—PIK3CG—brain cancer	3.35e-06	0.000454	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—APC—brain cancer	3.35e-06	0.000454	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—PIK3CG—brain cancer	3.21e-06	0.000436	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling by GPCR—EGFR—brain cancer	3.09e-06	0.000419	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling by GPCR—EGFR—brain cancer	3.08e-06	0.000418	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling by GPCR—EGFR—brain cancer	3.05e-06	0.000414	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—RELA—brain cancer	2.65e-06	0.00036	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—RELA—brain cancer	2.64e-06	0.000358	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—ERBB2—brain cancer	2.63e-06	0.000357	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—ERBB2—brain cancer	2.62e-06	0.000356	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—RELA—brain cancer	2.62e-06	0.000355	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—ERBB2—brain cancer	2.6e-06	0.000353	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—IL2—brain cancer	2.39e-06	0.000324	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—IL2—brain cancer	2.38e-06	0.000323	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—IL2—brain cancer	2.36e-06	0.00032	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—CCND1—brain cancer	2.33e-06	0.000316	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—CCND1—brain cancer	2.32e-06	0.000315	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—CTNNB1—brain cancer	2.3e-06	0.000313	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—CCND1—brain cancer	2.3e-06	0.000312	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—CTNNB1—brain cancer	2.3e-06	0.000312	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—CTNNB1—brain cancer	2.27e-06	0.000309	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—VEGFA—brain cancer	2.03e-06	0.000275	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—VEGFA—brain cancer	2.02e-06	0.000274	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—STAT3—brain cancer	2.01e-06	0.000272	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—VEGFA—brain cancer	2e-06	0.000272	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—STAT3—brain cancer	2e-06	0.000272	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—STAT3—brain cancer	1.98e-06	0.000269	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—MYC—brain cancer	1.87e-06	0.000253	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—MYC—brain cancer	1.86e-06	0.000252	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—MYC—brain cancer	1.84e-06	0.00025	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—EGFR—brain cancer	1.83e-06	0.000248	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—EGFR—brain cancer	1.82e-06	0.000247	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—EGFR—brain cancer	1.8e-06	0.000244	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—TP53—brain cancer	1.53e-06	0.000208	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—TP53—brain cancer	1.53e-06	0.000207	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—TP53—brain cancer	1.51e-06	0.000205	CbGpPWpGaD
